<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 18 Jun 2026 08:46:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/CytoSorbents+to+Present+at+the+Life+Sciences+Forum+on+June+24%2C+2026+and+Meet+Virtually+with+Investors+on+June+30%2C+2026/26663439.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PRINCETON, N.J., June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TaHt_w_o1PTPT1PGgr8XRWvctrmbUAKrOfoW-U1XfasYPhoB1rHwyUKQfp7_iI1K-niOUy_itEmrSHE8UoWusncfj2GJ6DBxDNue8DnQge8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;CytoSorbents Corporation&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that Dr. Phillip Chan, Chief Executive Officer, will present at the Life Sciences Forum hosted by &lt;a target=&quot;_blank&quot; href=&quot;http://VirtualInvestorConferences.com&quot;&gt;VirtualInvestorConferences.com&lt;/a&gt; on Wednesday, June 24, 2026 and provide an overview and update on the Company. Following the presentation, Zacks Analyst Mr. Thomas Kerr will host a brief Q&amp;amp;A session with Dr. Chan and Mr. Peter Mariani, Chief Financial Officer.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;PRESENTATION DETAILS&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CytoSorbents+to+Present+at+the+Life+Sciences+Forum+on+June+24%2C+2026+and+Meet+Virtually+with+Investors+on+June+30%2C+2026/26663439.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/CytoSorbents+to+Present+at+the+Life+Sciences+Forum+on+June+24%2C+2026+and+Meet+Virtually+with+Investors+on+June+30%2C+2026/26663439.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PRINCETON, N.J., June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TaHt_w_o1PTPT1PGgr8XRWvctrmbUAKrOfoW-U1XfasYPhoB1rHwyUKQfp7_iI1K-niOUy_itEmrSHE8UoWusncfj2GJ6DBxDNue8DnQge8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;CytoSorbents Corporation&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that Dr. Phillip Chan, Chief Executive Officer, will present at the Life Sciences Forum hosted by &lt;a target=&quot;_blank&quot; href=&quot;http://VirtualInvestorConferences.com&quot;&gt;VirtualInvestorConferences.com&lt;/a&gt; on Wednesday, June 24, 2026 and provide an overview and update on the Company. Following the presentation, Zacks Analyst Mr. Thomas Kerr will host a brief Q&amp;amp;A session with Dr. Chan and Mr. Peter Mariani, Chief Financial Officer.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;PRESENTATION DETAILS&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CytoSorbents+to+Present+at+the+Life+Sciences+Forum+on+June+24%2C+2026+and+Meet+Virtually+with+Investors+on+June+30%2C+2026/26663439.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/CytoSorbents+to+Present+at+the+Life+Sciences+Forum+on+June+24%2C+2026+and+Meet+Virtually+with+Investors+on+June+30%2C+2026/26663439.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PRINCETON, N.J., June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TaHt_w_o1PTPT1PGgr8XRWvctrmbUAKrOfoW-U1XfasYPhoB1rHwyUKQfp7_iI1K-niOUy_itEmrSHE8UoWusncfj2GJ6DBxDNue8DnQge8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;CytoSorbents Corporation&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that Dr. Phillip Chan, Chief Executive Officer, will present at the Life Sciences Forum hosted by &lt;a target=&quot;_blank&quot; href=&quot;http://VirtualInvestorConferences.com&quot;&gt;VirtualInvestorConferences.com&lt;/a&gt; on Wednesday, June 24, 2026 and provide an overview and update on the Company. Following the presentation, Zacks Analyst Mr. Thomas Kerr will host a brief Q&amp;amp;A session with Dr. Chan and Mr. Peter Mariani, Chief Financial Officer.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;PRESENTATION DETAILS&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/CytoSorbents+to+Present+at+the+Life+Sciences+Forum+on+June+24%2C+2026+and+Meet+Virtually+with+Investors+on+June+30%2C+2026/26663439.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/CytoSorbents+to+Present+at+the+Life+Sciences+Forum+on+June+24%2C+2026+and+Meet+Virtually+with+Investors+on+June+30%2C+2026/26663439.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;PRINCETON, N.J., June  18, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=TaHt_w_o1PTPT1PGgr8XRWvctrmbUAKrOfoW-U1XfasYPhoB1rHwyUKQfp7_iI1K-niOUy_itEmrSHE8UoWusncfj2GJ6DBxDNue8DnQge8=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;CytoSorbents Corporation&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that Dr. Phillip Chan, Chief Executive Officer, will present at the Life Sciences Forum hosted by &lt;a target=&quot;_blank&quot; href=&quot;http://VirtualInvestorConferences.com&quot;&gt;VirtualInvestorConferences.com&lt;/a&gt; on Wednesday, June 24, 2026 and provide an overview and update on the Company. Following the presentation, Zacks Analyst Mr. Thomas Kerr will host a brief Q&amp;amp;A session with Dr. Chan and Mr. Peter Mariani, Chief Financial Officer.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;PRESENTATION DETAILS&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/CytoSorbents+to+Present+at+the+Life+Sciences+Forum+on+June+24%2C+2026+and+Meet+Virtually+with+Investors+on+June+30%2C+2026/26663439.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>Form  4          Cytosorbents Corp         For: Jun 15  Filed by: MARIANI PETER J</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cytosorbents+Corp+++++++++For%3A+Jun+15++Filed+by%3A+MARIANI+PETER+J/26650265.html</link>
   <description>si-local-file:///var/storage/secattach/20260616/26650265.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cytosorbents+Corp+++++++++For%3A+Jun+15++Filed+by%3A+MARIANI+PETER+J/26650265.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>Form  4          Cytosorbents Corp         For: Jun 15  Filed by: MARIANI PETER J</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cytosorbents+Corp+++++++++For%3A+Jun+15++Filed+by%3A+MARIANI+PETER+J/26650265.html</link>
   <description>si-local-file:///var/storage/secattach/20260616/26650265.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cytosorbents+Corp+++++++++For%3A+Jun+15++Filed+by%3A+MARIANI+PETER+J/26650265.html</guid>
   <pubDate>Tue, 16 Jun 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>Form  4          Cytosorbents Corp         For: Jun 12  Filed by: Chan Phillip P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cytosorbents+Corp+++++++++For%3A+Jun+12++Filed+by%3A+Chan+Phillip+P./26648899.html</link>
   <description>si-local-file:///var/storage/secattach/20260615/26648899.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cytosorbents+Corp+++++++++For%3A+Jun+12++Filed+by%3A+Chan+Phillip+P./26648899.html</guid>
   <pubDate>Mon, 15 Jun 2026 18:24:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>Form  4          Cytosorbents Corp         For: Jun 12  Filed by: Chan Phillip P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cytosorbents+Corp+++++++++For%3A+Jun+12++Filed+by%3A+Chan+Phillip+P./26648899.html</link>
   <description>si-local-file:///var/storage/secattach/20260615/26648899.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Cytosorbents+Corp+++++++++For%3A+Jun+12++Filed+by%3A+Chan+Phillip+P./26648899.html</guid>
   <pubDate>Mon, 15 Jun 2026 18:24:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>Form  PRE 14A    Cytosorbents Corp         For: Jun 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Cytosorbents+Corp+++++++++For%3A+Jun+11/26636678.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636678.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Cytosorbents+Corp+++++++++For%3A+Jun+11/26636678.html</guid>
   <pubDate>Thu, 11 Jun 2026 17:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>Form  PRE 14A    Cytosorbents Corp         For: Jun 11</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Cytosorbents+Corp+++++++++For%3A+Jun+11/26636678.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636678.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++Cytosorbents+Corp+++++++++For%3A+Jun+11/26636678.html</guid>
   <pubDate>Thu, 11 Jun 2026 17:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>Form  10-Q       Cytosorbents Corp         For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cytosorbents+Corp+++++++++For%3A+Mar+31/26486477.html</link>
   <description>si-local-file:///var/storage/secattach/20260513/26486477.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cytosorbents+Corp+++++++++For%3A+Mar+31/26486477.html</guid>
   <pubDate>Wed, 13 May 2026 16:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>Form  10-Q       Cytosorbents Corp         For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cytosorbents+Corp+++++++++For%3A+Mar+31/26486477.html</link>
   <description>si-local-file:///var/storage/secattach/20260513/26486477.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cytosorbents+Corp+++++++++For%3A+Mar+31/26486477.html</guid>
   <pubDate>Wed, 13 May 2026 16:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>Form  8-K        Cytosorbents Corp         For: May 13</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cytosorbents+Corp+++++++++For%3A+May+13/26485886.html</link>
   <description>si-local-file:///var/storage/secattach/20260513/26485886.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cytosorbents+Corp+++++++++For%3A+May+13/26485886.html</guid>
   <pubDate>Wed, 13 May 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>Form  8-K        Cytosorbents Corp         For: May 13</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cytosorbents+Corp+++++++++For%3A+May+13/26485886.html</link>
   <description>si-local-file:///var/storage/secattach/20260513/26485886.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cytosorbents+Corp+++++++++For%3A+May+13/26485886.html</guid>
   <pubDate>Wed, 13 May 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	  </item>
  <item>
   <title>Cytosorbents (CTSO) Misses Q1 EPS by 1c</title>
   <link>http://www.streetinsider.com/Earnings/Cytosorbents+%28CTSO%29+Misses+Q1+EPS+by+1c/26485643.html</link>
   <description>&lt;p&gt;Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $9.23 million.&lt;/p&gt;
&lt;p&gt;For earnings history and earnings-related data on Cytosorbents (CTSO) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=CTSO&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/Cytosorbents+%28CTSO%29+Misses+Q1+EPS+by+1c/26485643.html</guid>
   <pubDate>Wed, 13 May 2026 16:00:49 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	  </item>
  <item>
   <title>CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update</title>
   <link>http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4688270-1&amp;amp;h=2389745047&amp;amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;amp;a=CytoSorbents+Corporation&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:CTSO&quot; idsrc=&quot;xmltag.org&quot; &gt;CytoSorbents Corporation&lt;/span&gt;&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. &lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</guid>
   <pubDate>Wed, 13 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19651963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21314198</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	  </item>
  <item>
   <title>CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update</title>
   <link>http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4688270-1&amp;amp;h=2389745047&amp;amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;amp;a=CytoSorbents+Corporation&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:CTSO&quot; idsrc=&quot;xmltag.org&quot; &gt;CytoSorbents Corporation&lt;/span&gt;&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. &lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</guid>
   <pubDate>Wed, 13 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19651963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21314198</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	  </item>
  <item>
   <title>CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update</title>
   <link>http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4688270-1&amp;amp;h=2389745047&amp;amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;amp;a=CytoSorbents+Corporation&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:CTSO&quot; idsrc=&quot;xmltag.org&quot; &gt;CytoSorbents Corporation&lt;/span&gt;&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. &lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</guid>
   <pubDate>Wed, 13 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19651963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21314198</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	  </item>
  <item>
   <title>CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update</title>
   <link>http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4688270-1&amp;amp;h=2389745047&amp;amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;amp;a=CytoSorbents+Corporation&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:CTSO&quot; idsrc=&quot;xmltag.org&quot; &gt;CytoSorbents Corporation&lt;/span&gt;&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. &lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</guid>
   <pubDate>Wed, 13 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19651963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21314198</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	  </item>
  <item>
   <title>CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update</title>
   <link>http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4688270-1&amp;amp;h=2389745047&amp;amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;amp;a=CytoSorbents+Corporation&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:CTSO&quot; idsrc=&quot;xmltag.org&quot; &gt;CytoSorbents Corporation&lt;/span&gt;&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. &lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</guid>
   <pubDate>Wed, 13 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19651963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21314198</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	  </item>
  <item>
   <title>CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update</title>
   <link>http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4688270-1&amp;amp;h=2389745047&amp;amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;amp;a=CytoSorbents+Corporation&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:CTSO&quot; idsrc=&quot;xmltag.org&quot; &gt;CytoSorbents Corporation&lt;/span&gt;&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. &lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</guid>
   <pubDate>Wed, 13 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19651963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21314198</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	  </item>
  <item>
   <title>CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update</title>
   <link>http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4688270-1&amp;amp;h=2389745047&amp;amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;amp;a=CytoSorbents+Corporation&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:CTSO&quot; idsrc=&quot;xmltag.org&quot; &gt;CytoSorbents Corporation&lt;/span&gt;&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. &lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</guid>
   <pubDate>Wed, 13 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19651963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21314198</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	  </item>
  <item>
   <title>CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update</title>
   <link>http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4688270-1&amp;amp;h=2389745047&amp;amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;amp;a=CytoSorbents+Corporation&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:CTSO&quot; idsrc=&quot;xmltag.org&quot; &gt;CytoSorbents Corporation&lt;/span&gt;&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. &lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</guid>
   <pubDate>Wed, 13 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19651963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21314198</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	  </item>
  <item>
   <title>CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update</title>
   <link>http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4688270-1&amp;amp;h=2389745047&amp;amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;amp;a=CytoSorbents+Corporation&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:CTSO&quot; idsrc=&quot;xmltag.org&quot; &gt;CytoSorbents Corporation&lt;/span&gt;&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. &lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</guid>
   <pubDate>Wed, 13 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19651963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21314198</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	  </item>
  <item>
   <title>CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update</title>
   <link>http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.nj.prnctn&quot; idsrc=&quot;xmltag.org&quot; &gt;PRINCETON, N.J.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;May 13, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;a target=&quot;_blank&quot; href=&quot;https://edge.prnewswire.com/c/link/?t=0&amp;amp;l=en&amp;amp;o=4688270-1&amp;amp;h=2389745047&amp;amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;amp;a=CytoSorbents+Corporation&quot; target=&quot;_blank&quot; rel=&quot;nofollow&quot;&gt;&lt;span value=&quot;NASDAQ-SMALL:CTSO&quot; idsrc=&quot;xmltag.org&quot; &gt;CytoSorbents Corporation&lt;/span&gt;&lt;/a&gt; (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. &lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
                </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html</guid>
   <pubDate>Wed, 13 May 2026 16:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.17150087</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19651963</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CTSO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03158501</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21314198</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.34929518</category>
   	  </item>
 </channel>
</rss>
